The Intravenous Immunoglobulin Market is expected to reach US$ 18.6 billion by 2028 from US$ 11.20 billion in 2021; it is estimated to grow at a CAGR of.
Toronto, ON (PRWEB) April 19, 2022 There is increasing interest in the Asia-Pacific (APAC) biotech industry in initiating early phase clinical trials in